Literature DB >> 21844303

Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.

Mopo Radebe1, Kriebashnie Nair, Fundisiwe Chonco, Karen Bishop, Jaclyn K Wright, Mary van der Stok, Ingrid V Bassett, Zenele Mncube, Marcus Altfeld, Bruce D Walker, Thumbi Ndung'u.   

Abstract

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1)-specific CD8(+) responses contribute to the decline in acute peak viremia following infection. However, data on the relative immunogenicity of CD8(+) T-cell epitopes during and after acute viremia are lacking.
METHODS: We characterized CD8(+) T-cell responses in 20 acutely infected, antiretroviral-naive individuals with HIV-1 subtype C infection using the interferon-γ enzyme-linked immunosorbent spot assay. Eleven of these had not fully seroconverted at the time of analysis. Viruses from plasma were sequenced within defined cytotoxic T-lymphocyte (CTL) cell epitopes for selected subjects.
RESULTS: At approximately 28 days after estimated initial infection, CD8(+) T-cell responses were directed against an average of 3 of the 410 peptides tested (range, 0-6); 2 individuals had no detectable responses at this time. At 18 weeks, the average number of peptides targeted had increased to 5 (range 0-11). Of the 56 optimal Gag CTL epitopes sequenced, 31 were wild-type in the infecting viruses, but only 11 of 31 elicited measurable CD8(+) T-cell responses.
CONCLUSIONS: These data demonstrate that the majority of CD8(+) responses are not elicited during acute HIV infection despite the presence of the cognate epitope in the infecting strain. There is a need to define factors that influence lack of induction of effective immune responses and the parameters that dictate immunodominance in acute infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844303      PMCID: PMC3156105          DOI: 10.1093/infdis/jir394

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

Authors:  Y Sun; E Iglesias; A Samri; G Kamkamidze; T Decoville; G Carcelain; B Autran
Journal:  J Immunol Methods       Date:  2003-01-15       Impact factor: 2.303

2.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection.

Authors:  Galit Alter; Alefia Merchant; Christos M Tsoukas; Danielle Rouleau; Roger P LeBlanc; Pierre Côté; Jean-Guy Baril; Réjean Thomas; Vinh-Kim Nguyen; Rafik-Pierre Sékaly; Jean-Pierre Routy; Nicole F Bernard
Journal:  J Infect Dis       Date:  2002-02-20       Impact factor: 5.226

4.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

Authors:  T M Allen; D H O'Connor; P Jing; J L Dzuris; B R Mothé; T U Vogel; E Dunphy; M E Liebl; C Emerson; N Wilson; K J Kunstman; X Wang; D B Allison; A L Hughes; R C Desrosiers; J D Altman; S M Wolinsky; A Sette; D I Watkins
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

5.  Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.

Authors:  Xu G Yu; Marylyn M Addo; Eric S Rosenberg; William R Rodriguez; Paul K Lee; Cecily A Fitzpatrick; Mary N Johnston; Daryld Strick; Philip J R Goulder; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.

Authors:  V Novitsky; P Gilbert; T Peter; M F McLane; S Gaolekwe; N Rybak; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.

Authors:  Marcus Altfeld; Marylyn M Addo; Raj Shankarappa; Paul K Lee; Todd M Allen; Xu G Yu; Almas Rathod; Jason Harlow; Kristin O'Sullivan; Mary N Johnston; Philip J R Goulder; James I Mullins; Eric S Rosenberg; Christian Brander; Bette Korber; Bruce D Walker
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

Authors:  M Altfeld; E S Rosenberg; R Shankarappa; J S Mukherjee; F M Hecht; R L Eldridge; M M Addo; S H Poon; M N Phillips; G K Robbins; P E Sax; S Boswell; J O Kahn; C Brander; P J Goulder; J A Levy; J I Mullins; B D Walker
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

View more
  19 in total

1.  Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.

Authors:  Stephanie A Freel; Ralph A Picking; Guido Ferrari; Haitao Ding; Christina Ochsenbauer; John C Kappes; Jennifer L Kirchherr; Kelly A Soderberg; Kent J Weinhold; Coleen K Cunningham; Thomas N Denny; John A Crump; Myron S Cohen; Andrew J McMichael; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

3.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

4.  CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.

Authors:  Catherine K Koofhethile; Zaza M Ndhlovu; Christina Thobakgale-Tshabalala; Julia G Prado; Nasreen Ismail; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Nonhlanhla Yende; Bruce D Walker; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

5.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.

Authors:  Mopo Radebe; Kamini Gounder; Mammekwa Mokgoro; Zaza M Ndhlovu; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Manjeetha Jaggernath; Bruce D Walker; Thumbi Ndung'u
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

6.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

Review 7.  The T-cell response to HIV.

Authors:  Bruce Walker; Andrew McMichael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

8.  Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.

Authors:  Zaza M Ndhlovu; Philomena Kamya; Nikoshia Mewalal; Henrik N Kløverpris; Thandeka Nkosi; Karyn Pretorius; Faatima Laher; Funsho Ogunshola; Denis Chopera; Karthik Shekhar; Musie Ghebremichael; Nasreen Ismail; Amber Moodley; Amna Malik; Alasdair Leslie; Philip J R Goulder; Søren Buus; Arup Chakraborty; Krista Dong; Thumbi Ndung'u; Bruce D Walker
Journal:  Immunity       Date:  2015-09-08       Impact factor: 31.745

9.  Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure.

Authors:  Jaclyn K Mann; Denis Chopera; Saleha Omarjee; Xiaomei T Kuang; Anh Q Le; Gursev Anmole; Ryan Danroth; Philip Mwimanzi; Tarylee Reddy; Jonathan Carlson; Mopo Radebe; Philip J R Goulder; Bruce D Walker; Salim Abdool Karim; Vladimir Novitsky; Carolyn Williamson; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u
Journal:  Virology       Date:  2014-09-03       Impact factor: 3.616

10.  Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.

Authors:  Doty B A Ojwach; Daniel MacMillan; Tarylee Reddy; Vladimir Novitsky; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u; Jaclyn K Mann
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.